A securities fraud class action has been filed against CoreWeave, Inc. for allegedly misrepresenting customer demand and concealing significant data center construction delays. The company's stock declined 16% on November 11, 2025, following guidance cuts attributed to third-party developer delays. Investors have until March 13, 2026, to request lead plaintiff status in the case filed in U.S. District Court for the District of New Jersey.

A class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) in the U.S. District Court for the District of New Jersey. The lawsuit alleges that CoreWeave issued false and misleading statements regarding its ability to meet customer demand and materially understated risks associated with its reliance on a single third-party data center supplier. Investors who purchased CoreWeave securities between March 28, 2025 and December 15, 2025 can apply to be lead plaintiff by March 13, 2026.

Securities litigation firm Holzer & Holzer, LLC announced investigations into Eos Energy Enterprises following the company's announcement of a $969.6 million net loss for 2025, with $746.8 million attributed to non-cash items. The stock price dropped following the earnings report. The firm is also investigating Camping World Holdings and reminding CoreWeave investors of an upcoming lead plaintiff deadline in a securities class action lawsuit.

CoreWeave stock plunged 20% after missing earnings expectations despite strong revenue growth of 110% to $1.57 billion. The company reported a $452 million net loss (worse than expected), widening operating losses, and disappointing Q1 2026 guidance of $1.9-2 billion versus consensus of $2.24 billion. Heavy debt servicing costs and aggressive $30 billion capex plans raised investor concerns about profitability despite strong demand signals.

CoreWeave (CRWV) shares fell over 11% in premarket trading after reporting Q4 2025 earnings that beat revenue expectations but disappointed on losses and guidance. The AI cloud infrastructure provider posted $1.57B in revenue (110% YoY growth) but reported a loss per share of $0.89 versus analyst expectations of $0.49-$0.72. Q1 2026 guidance of $1.9-$2B fell short of Wall Street's $2.29B expectation. The company's aggressive capital expenditure plan, $21.37B in total debt, and negative free cash flow of $5.27B have raised concerns about sustainability.

Holzer & Holzer, LLC announces lead plaintiff deadlines for shareholder class action lawsuits against CoreWeave, Bath & Body Works, and Vistagen Therapeutics. The lawsuits allege materially false statements regarding CoreWeave's ability to meet customer demand, Bath & Body Works's customer growth and net sales, and Vistagen's Phase 3 trial risks. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by March 13-16, 2026.

CoreWeave, Inc. (CRWV) faces a securities class action lawsuit alleging the company failed to disclose material information between March 28, 2025 and December 15, 2025. Investors are accused of overstating their ability to meet customer demand and understating risks from reliance on a single third-party data center supplier. The lead plaintiff deadline is March 13, 2026.

CoreWeave, an AI infrastructure company, has surged 123% since its March 2025 IPO but remains volatile. Despite a 51% decline from its 52-week high, the company's massive $56 billion revenue backlog, expanding data center capacity, and expected 4x revenue growth by 2027 position it as a strong long-term buy. With McKinsey projecting $1.7 trillion in AI data center spending by 2030, CoreWeave is well-positioned to capitalize on this secular growth opportunity.

CoreWeave, Inc. faces a class action securities fraud lawsuit alleging the company made materially false statements about its ability to meet customer demand and understated risks from reliance on a single data center supplier. The lawsuit covers the period from March 28, 2025 to December 15, 2025, during which CoreWeave's stock declined significantly following failed merger with Core Scientific and subsequent revelations of data center delays. Investors have until March 13, 2026 to file lead plaintiff motions.

CoreWeave, an AI data center company, has surged 140% since its IPO but faces significant challenges. While sales grew 133% to $1.3 billion in Q3 and Nvidia invested $2 billion, the company remains unprofitable, carries nearly $19 billion in debt, and relies on just two customers for 77% of revenue. The analyst suggests only a very small position is warranted given the risks.

Law firm Hagens Berman is investigating a class action lawsuit against CoreWeave, Inc. (NASDAQ: CRWV) alleging the company misled investors about its ability to scale AI infrastructure and meet revenue guidance. The suit claims CoreWeave concealed significant delays at its Denton, Texas data center facility and overstated its capacity to recognize revenue from its backlog. Following revelations of construction delays in December 2025, CoreWeave's market capitalization plummeted by approximately $14 billion. The Lead Plaintiff Deadline is March 13, 2026.

Cathie Wood's Ark Invest added to positions in Figma, CoreWeave, and Recursion Pharmaceuticals on Friday as all three growth stocks trade significantly below their 2025 highs. Figma showed strong Q4 results with 40% revenue growth and improved margins, while CoreWeave benefits from AI infrastructure demand. Recursion faces headwinds after Nvidia exited its stake, though the company remains a clinical-stage AI-driven biotech play.